Home Newsfeeds Oppenheimer Initiates Coverage On PTC with Perform Rating

Oppenheimer Initiates Coverage On PTC with Perform Rating

Oppenheimer analyst Ken Wong initiates coverage on PTC (NASDAQ:PTC) with a Perform rating.

byBenzinga Newsdesk

July 27, 2022

1 minute read

Oppenheimer analyst Ken Wong initiates coverage on PTC (NASDAQ:PTC) with a Perform rating.

News

Google Cloud Unveils New AI Tools for Retailers

By Benzinga Newsdesk

January 13, 9:21 AM

State-of-the-art shelf checking AI solution utilizes Google's recognition of billions of products Google Cloud's Discovery AI solutions launches new AI features to power ecommerce sites with modern browsing

GOOG

What’s Going On With Small-Cap Cancer Focused XBiotech On Tuesday?

By Vandana Singh

June 18, 1:08 PM

XBiotech reveals results from its Phase 1/Phase 2 1-BETTER Study for advanced pancreatic cancer, highlighting the safety and tolerability of Natrunix with the ONIVYDE + 5-Fluorouracil + Leucovorin regimen.

XBIT

MEI Pharma, Kyowa Kirin Earlier Announced Discontinuation Of Zandelisib Development Outside Of Japan Following Recent FDA Meeting

By Michael Horton

December 5, 6:40 PM

MEI Pharma, Inc. (NASDAQ:MEIP), a pharmaceutical company focused on advancing new therapies for cancer, and Kyowa Kirin Co., Ltd. (Kyowa Kirin, TSE: 4151), a Japan-based global specialty pharmaceutical company creating

MEIP